AzTrials
AzTrials

Maternal DepressionNCT04092010

Improving Preschool Outcomes by Addressing Maternal Depression in Head Start

A study testing Problem-solving education (PSE) and Engagement sessions in people with Maternal Depression, run by Brown University at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Within a research network of Head Start centers in Massachusetts, an efficacy trial of a stepped-care intervention (SCI) to address maternal depression, using intervention components that both prevent depression and help those in major depressive episode (MDE) engage with care, will be conducted. Read more about this study

Who is it for?
Any age, women only
Conditions the study is for
Maternal Depression
What is being tested?
Problem-solving education (PSE) and Engagement sessions
Could I receive a placebo?
No, everyone receives an active treatment
How many people
388 participants
Where
1 siteUnited States
Study dates
16 Aug 2023to 30 Apr 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Mother of a 0 to 5-year-old Head Start child
  • Mother speaks English or Spanish

Who cannot join

  • Mother with suicidal ideation
  • Mother with cognitive limitation

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Boston Medical Center

    Boston, Massachusetts, 02119

Other trials in United States

About this study

Within a research network of Head Start centers in Massachusetts, an efficacy trial of a stepped-care intervention (SCI) to address maternal depression, using intervention components that both prevent depression and help those in major depressive episode (MDE) engage with care, will be conducted. Both the prevention and engagement components of the model have strong, supportive randomized trial evidence for both their efficacy and safety; but they have yet to be synthesized and tested within a coordinated intervention, applicable to a broad population base. Stepped-care interventions are commonly used in mental health service projects, in which the intensity or type of service is calibrated to the severity of illness.

Read the detailed description

This research study is a community-based efficacy trial (n=388) of a stepped-care model intervention to strengthen the capacity of Head Start to address parental depression and related adversities. Head Start mothers with symptoms of depressed mood or anhedonia, and their Head Start children, are enrolled across 12 Head Start centers.

The research study aims to improve developmental outcomes for Head Start children by delivering stepped care intervention that incorporates depression prevention and linkage to formal mental health care to mothers. Mothers with low baseline depressive symptoms are offered a problem-solving intervention while mothers with greater symptoms are offered engagement sessions to link them to formal mental health services. At each problem-solving session participant's symptoms are assessed and if the symptoms meet pre-specified 'step-up' criteria, they are converted to Engagement sessions.

Over 12 months, the intervention's effect will be assessed on a series of outcome measures for mothers; mechanisms by which maternal depression is theorized to impact young children; and child outcomes.

Being tested
Problem-solving education (PSE), Engagement sessions, Usual care
Keywords
Stepped care intervention, Problem solving education, Engagement session, Head Start, Preschool children

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Problem-solving education (PSE)Behavioural

    PSE will be offered to mothers with low baseline depressive symptoms (the first, preventive step of the SCI). PSE participants will have their symptoms assessed at each session and will convert to Engagement Sessions if they meet pre-specified 'step up' criteria.

  • Engagement sessionsBehavioural

    Engagement sessions will be offered to mothers with greater depressive symptoms to link them to formal mental health services (the second, referral step of the SCI)

  • Usual careBehavioural

    Normal services provided children and their mothers in Head Start

Study groups in NCT04092010
Study groupRoleWhat they receive
Stepped-care intervention (SCI) groupExperimentalIn the SCI group, mothers with low baseline depressive symptoms are offered the problem-solving education (PSE) prevention intervention, and mothers with greater depressive symptoms are offered Engagement Sessions.
Receives: Behavioral: Problem-solving education (PSE); Behavioral: Engagement sessions
Usual care control groupActive comparatorFamilies in the control group will receive usual Head Start services.
Receives: Behavioral: Usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in incident rates of moderate to severe maternal depressive symptoms based on the QIDS

    The Quick Inventory of Depressive Symptoms (QIDS) will be used to assess the incidence of moderate to severe depressive symptom episodes, as defined by a QIDS score ≥ 11. The QIDS is a 16 item self-administered instrument with potential responses for each item of 0 to 3. Higher scores are associated with greater depressive symptoms.

    Measured: Baseline, 2, 4, 6, 8, 10, 12 months follow-up

  2. Change in the mean maternal depressive symptoms based on the QIDS

    The Quick Inventory of Depressive Symptoms will be used to assess depressive symptoms. The QIDS is a 16 item self-administered instrument with potential responses for each item of 0 to 3. Higher scores are associated with greater depressive symptoms. The mean QIDS scores will be calculated for the baseline and each follow up period.

    Measured: Baseline, 2, 4, 6, 8, 10, 12 months follow-up

Secondary outcomes (14)
  1. Rate of participants engaged with care based on 1 or more psycho/pharmacotherapy visits or psychiatric medication prescription

    The investigators have adapted the services section of the Collaborative Psychiatric Epidemiology Surveys, operationalized into engagement with care. This will be defined as ≥ 1 visit for psychotherapy or pharmacotherapy with a behavioral health specialist (social worker, psychologist, psychiatrist, psychiatric nurse); or a prescription for psychiatric medication from any medical practitioner.

    Measured: Baseline, 2, 4, 6, 8, 10, 12 months follow-up

  2. Rate of participants retained in care based on 4 or more psycho/pharmacotherapy visits or psychiatric medication prescription

    The investigators have adapted the services section of the Collaborative Psychiatric Epidemiology Surveys, operationalized into retention in care. This will be defined as ≥ 4 visit for psychotherapy or pharmacotherapy with a behavioral health specialist (social worker, psychologist, psychiatrist, psychiatric nurse); or a prescription for psychiatric medication from any medical practitioner.

    Measured: 2, 4, 6, 8, 10, 12 months

  3. Rate of participants who received evidence-based care defined by psychotherapy or antidepressant medication prescription

    The investigators have adapted the services section of the Collaborative Psychiatric Epidemiology Surveys, operationalized into evidence-based care reflecting either psychotherapy or antidepressant medication.

    Measured: 2, 4, 6, 8, 10, 12 months

  4. Rate of participants who received primary-care based services

    The investigators have adapted the services section of the Collaborative Psychiatric Epidemiology Surveys, operationalized into primary care-based services.

    Measured: 2, 4, 6, 8, 10, 12 months

  5. Burden of illness for depression

    The Individual Burden of Illness Index for Depression (IBI-D) is a valid and reliable quality of life (QoL) scale, calculated as a composite of the QIDS, the QoL Enjoyment and Satisfaction Questionnaire, and the Work and Social Adjustment Scale

    Measured: baseline; 6, 12 months

  6. Child absenteeism from Head Start

    Head Start centers will furnish us with monthly absentee rates for all families that provide explicit permission. These will be analyzed as count data against day of eligible attendance.

    Measured: baseline; 6, 12 months

  7. Caregiver-Teacher Report Form

    This valid and reliable scale will be filled out by Head Start teachers. It measures emotional reactivity, anxiety/depression, somatic complaints, emotional withdrawal, attention problems, and aggressive behavior.

    Measured: baseline; 6, 12 months

  8. Social Skills Improvement System - Rating Scales

    This valid and reliable scale will be filled out by Head Start teachers. It assesses social skills and problem behaviors for children at risk of interpersonal difficulties.

    Measured: baseline; 6, 12 months

  9. Bracken School Readiness Assessment

    This scale assesses 85 foundational concepts, including colors, letters, numbers, size/ comparison, and shapes. Assess effect of intervention on child cognitive functioning and school readiness.

    Measured: baseline; 6, 12 months

  10. Perceived Stress

    Assess with The Perceived Stress Scale, domains of which include unpredictability, lack of control, burden overload, and stressful circumstances.

    Measured: baseline, 4, 8, 12 months

  11. Behavioral Activation for Depression

    Assess with The Behavioral Activation for Depression Scale (BADS) includes four affective and functional dimensions: activation, avoidance/rumination, work/school impairment, and social impairment.

    Measured: baseline, 4, 8, 12 months

  12. Coping Strategies

    Assess with The Brief COPE (Coping Orientation to Problems) which measures 14 different adaptive and problematic coping styles. Will also use problem-focused and avoidant subscales.

    Measured: baseline, 4, 8, 12 months

  13. Parent-Child Interaction

    Assess with The Dyadic Parent-Child Interaction Coding System (4th Edition).

    Measured: baseline, 6, 12 months

  14. Family Conflict

    Assess with The 80-item Conflicts and Problem-Solving Scale. Likert scales rate aspects of family conflict known to affect children: 1) number of major and minor conflicts in the past year; 2) family disagreement in 21 areas; 3) frequency of 13 conflict resolution strategies; 4) frequency of 44 conflict tactics.

    Measured: Baseline, 6, 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2019
  2. Study start16 Aug 2023
  3. Primary completion30 Apr 2028 (estimated)
  4. Study completion30 Apr 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
388 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04092010
Sponsor's protocol ID
2022003398
Other IDs
1R01HD092456-01A1
Status last verified
Aug 2026
First submitted
13 Sep 2019
Last updated
6 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Deidentified individual participant data that underlie the results reported for all primary and secondary outcome measures will be made available (text, tables, figures, and appendices).

Questions about this trial

What is this clinical trial studying?

A study testing Problem-solving education (PSE) and Engagement sessions in people with Maternal Depression, run by Brown University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 6 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in incident rates of moderate to severe maternal depressive symptoms based on the QIDS (time frame: Baseline, 2, 4, 6, 8, 10, 12 months follow-up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in